Agios Pharmaceuticals, Inc. (AGIO) vs Maravai LifeSciences Holdings, Inc. (MRVI)
Agios Pharmaceuticals, Inc. and Maravai LifeSciences Holdings, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Maravai LifeSciences Holdings, Inc. are of similar size ($2.0B and $2.0B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against −5.03%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−37.1% vs −418.2%) and the higher return on invested capital (−15.8% vs −70.2%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 13 and Agios Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | AGIO | MRVI | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 34.89% | 65.16% |
| Operating margin | (466.78%) | (56.08%) | 0.00% |
| Net margin | (418.24%) | (37.07%) | 0.00% |
| Free cash flow margin | (371.43%) | (17.17%) | 0.00% |
| Return on equity | (34.34%) | (18.79%) | (57.72%) |
| Return on assets | (31.89%) | (10.31%) | (49.22%) |
| Return on invested capital | (70.24%) | (15.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack